Integrated MIP-Aptamer Biosensors Achieve Enhanced Selectivity for Small Molecule Detection Across Diagnostics

September 6, 2026

Analytical Chemistry | ACS Publications USA

Overview

A review in Analytical Chemistry highlights the significant progress in biosensors integrating molecularly imprinted polymers (MIPs) and aptamers, revolutionizing detection across life sciences, healthcare, food safety, and environmental monitoring. This combined approach leverages MIPs’ structural stability with aptamers’ high specificity, dramatically improving selectivity, anti-interference capabilities, cost-effectiveness, and response speed for diverse analytes. Electrochemical MIP-Apt sensors, particularly favored for small molecule detection, employ embedded structures to protect against nuclease degradation and minimize matrix interference, expanding their potential as high-accuracy diagnostic tools.

In Depth

Key Findings

A review published in Analytical Chemistry reveals that biosensors integrating molecularly imprinted polymers (MIPs) and aptamers have achieved substantial performance enhancements in sensitive and highly selective detection of small molecules. This synergistic strategy combines the robust structural stability of MIPs with the exceptional target specificity of aptamers, leading to significant improvements in selectivity, anti-interference capability, cost-efficiency, and response speed compared to conventional technologies.

Technical & Clinical Details

The review demonstrates the broad applicability of MIP-aptamer integrated biosensors across various fields, including life sciences, healthcare, food safety, and environmental monitoring, for detecting diverse targets. Of particular note is the frequent adoption of electrochemical MIP-apt sensors for small molecule detection. These sensors utilize embedded structures that offer protection against nuclease degradation and effectively reduce non-specific interference from complex biological matrices. This design is expected to enhance diagnostic accuracy, yielding more reliable analytical results, which is critical for clinical and field applications.

Background & Context

Biosensor technology is an indispensable tool in modern society, where rapid and precise detection is often critical. However, existing biosensors have faced challenges such as non-specific binding in complex sample matrices, limitations in long-term stability, and high production costs. MIPs, as synthetic recognition receptors, have gained attention for their high stability and cost-effectiveness but often suffer from specificity issues compared to natural bioreceptors. Aptamers, conversely, offer high specificity and versatility in binding diverse targets but can have structural stability limitations. The integration of these two technologies effectively mitigates their individual weaknesses, paving the way for the development of high-performance biosensors with broad impact on diagnostics and monitoring.

Strategic Significance & Outlook

Looking forward, MIP-aptamer integrated biosensors are anticipated to see expanded clinical applications and integration into point-of-care testing (POCT) devices. The combination with embedded structures and microfluidic technologies promises the development of smaller, more automated systems. This will facilitate groundbreaking advancements in areas such as early disease diagnosis, personalized medicine, and rapid infectious disease screening, transforming many aspects of healthcare. Furthermore, this technology is projected to play a crucial role in ensuring food safety and monitoring environmental pollutants, offering robust and cost-effective solutions.

Source: https://pubs.acs.org/ancham/article/98/34/24605/5260995/Development-and-Applications-of-Biosensors

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.